The number of people with susceptibility test result for rifampicin in Congo
Congo: The number of people with susceptibility test result for rifampicin was 2,015 in 2021. ◆ Volatile
Latest (2021)
2,015
Change on year
down 50.8%
World rank
47th
of 155 countries
All-time high
4,095
in 2020
All-time low
74
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Congo, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Congo recorded 2,015 for the number of people with susceptibility test result for rifampicin in 2021.
Compared with earlier readings it is down 50.8% on the previous year and up 2,623.0% over five years.
Congo ranks 47th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Congo, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 74 | — |
| 2018 | 587 | +693.2% |
| 2019 | 1,202 | +104.8% |
| 2020 | 4,095 | +240.7% |
| 2021 | 2,015 | -50.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 621 | 74 | 1,202 | 3 |
| 2020s | 3,055 | 2,015 | 4,095 | 2 |
Countries ranked near Congo
- 44 Argentina 2,309 compare
- 45 Hong Kong, China 2,181 compare
- 46 Guatemala 2,022 compare
- 48 Guinea-Bissau 1,934 compare
- 49 Kyrgyzstan 1,932 compare
- 50 Tajikistan 1,862 compare
More health data for Congo
- Un projection of annual infant deaths, annual growth rate -0.4813 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9705 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 759.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,688 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 11 (2025)
- Population ages 00-04, female, annual growth rate 1.44 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0695 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.45 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Congo?
- The number of people with susceptibility test result for rifampicin in Congo was 2,015 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Congo?
- The highest recorded value was 4,095 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Congo?
- The lowest recorded value was 74 in 2017.
- How does Congo rank for the number of people with susceptibility test result for rifampicin?
- Congo ranks 47th out of 155 countries with data for 2021.
- Where does this Congo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).